Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Hepatology. 2017 Jul 20;66(3):922–935. doi: 10.1002/hep.29244

Fig. 2.

Fig. 2

VLX103 decreases cell death and increases survival. (A) TUNEL-stained livers from mice with the indicated treatments (200×). (B) Quantification of TUNEL-positive cells per high power field (HPF) (*P<0.0002 as compared to PBS + GalN/LPS; n=6-7). (C) Percentage survival after pretreatment with PBS or the indicated VLX103 concentrations and GalN/LPS (P<0.004 for 40 mg/kg and P<0.001 for 50 mg/kg; n=6-12).